Crestovo Investor LLC is Director of Finch Therapeutics Group, Inc.. Currently has a direct ownership of 12.6 Million shares of FNCH, which is worth approximately $137 Million. The most recent transaction as insider was on Mar 23, 2021, when has been sold 735,294 shares (Common Stock) at a price of $17.0 per share, resulting in proceeds of $12,499,998. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.6M
0% 3M change
0% 12M change
Total Value Held $137 Million

Crestovo Investor LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 23 2021
BUY
Open market or private purchase
$12,499,998 $17.0 p/Share
735,294 Added 5.5%
12,641,441 Common Stock
Mar 23 2021
BUY
Conversion of derivative security
-
11,906,147 Added 50.0%
11,906,147 Common Stock
CIL

Crestovo Investor LLC

Director
Greenwich, CT

Track Institutional and Insider Activities on FNCH

Follow Finch Therapeutics Group, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FNCH shares.

Notify only if

Insider Trading

Get notified when an Finch Therapeutics Group, Inc. insider buys or sells FNCH shares.

Notify only if

News

Receive news related to Finch Therapeutics Group, Inc.

Track Activities on FNCH